Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

Etats-Unis|Canada
English|French

Dicerna Pharmaceutic

(NASDAQ: DRNA)
Ajouter à Portefeuille
-1.71 (-8.63%)
en date du Apr 7, 2020

Profil
Symbole DRNA
Marché NASDAQ
Informations de contact
33 HAYDEN AVENUE
LEXINGTON, MA USA
P: 617-621-8097
Président Douglas M. Fambrough
Bénéfices à vue d'oeuil
Bénéfices 12/31/19
-0.58
09/30/19
-0.45
06/30/19
-0.35
03/31/19
-0.38
Ratio prix/bénéfices N/A
Croissance du BPA 168.47
Most Recent Earnings ($) -0.58
Annual EPS ($) -1.76
Résumé business
Dicerna Pharmaceuticals Inc. is focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers. The company uses its proprietary RNA interference technology platform primarily in the United States and internationally. Dicerna Pharmaceuticals Inc. is headquartered in Watertown Massachusetts.
Industrie/Secteur SIC-2834 Pharmaceutical Preparations
Medical - Biomedical
Indices Nasdaq Composite
Indices Russell 3000
Indices Russell 2000